Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...

Immunological Memory

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Development of Immunocompetence

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

4-anilinoquinoline triazines: a novel class of hybrid antimalarial agents.

European journal of medicinal chemistry·2011

Same author

Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice.

The Journal of cell biology·2010

Same author

Buffalo hepcidin: characterization of cDNA and study of antimicrobial property.

Veterinary research communications·2010

Same author

High viral load and deregulation of the progesterone receptor signaling pathway: association with hepatitis E-related poor pregnancy outcome.

Journal of hepatology·2010

Same author

Gα13 and Rho mediate endosomal trafficking of CXCR4 into Rab11+ vesicles upon stromal cell-derived factor-1 stimulation.

Journal of immunology (Baltimore, Md. : 1950)·2010

Same author

Dlk1 is necessary for proper skeletal muscle development and regeneration.

PloS one·2010

Same journal

Artificial Intelligence Colposcopy Models for Cervical Cancer Screening and Diagnosis: A Systematic Review and Meta-Analysis.

Journal of obstetrics and gynaecology of India·2026

Same journal

Van Wyk Grumbach Syndrome: Case of Hemoperitoneum with Multiple Ovarian Cysts in a Girl with Precocious Puberty.

Journal of obstetrics and gynaecology of India·2026

Same journal

A Randomized Controlled Trial to Compare Vaginal Dinoprostone Pessary with Intracervical Dinoprostone Gel for Pre-induction Cervical Ripening.

Journal of obstetrics and gynaecology of India·2026

Same journal

Clinical and Psychosocial Characteristics of Women with Vaginismus: A Retrospective Descriptive Study from a Sexual Health Clinic in India.

Journal of obstetrics and gynaecology of India·2026

Same journal

Successful perinatal outcome of DCDA twin pregnancy in a bicorporeal uterus.

Journal of obstetrics and gynaecology of India·2026

Same journal

New-born Screening for Mitochondrial Disorders is Useful for Genetic Counseling and Early Treatment when Available.

Journal of obstetrics and gynaecology of India·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 27, 2026

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage

Published on: August 4, 2021

Immunomodulation in recurrent miscarriage.

¹Department of Obstetrics & Gynecology, Maulana Azad Medical College & Lok Nayak Hospital, 13 B, DDA Flats, Ber Sarai, New Delhi, 110016 India.

Journal of Obstetrics and Gynaecology of India

|June 27, 2014

Summary

This summary is machine-generated.

Recurrent miscarriage (RM) often lacks clear causes, potentially involving immune system imbalances. Further research is needed to understand immune factors and develop effective treatments for unexplained RM.

Keywords:

Immune system Immunomodulation Pregnancy Recurrent pregnancy loss

More Related Videos

Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells

Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells

Published on: October 13, 2023

Author Spotlight: Multiplex Immunohistochemistry for Understanding Immune Regulation by Uterine NK Cells in Pregnancy

Author Spotlight: Multiplex Immunohistochemistry for Understanding Immune Regulation by Uterine NK Cells in Pregnancy

Published on: October 25, 2024

Related Experiment Videos

Last Updated: Apr 27, 2026

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage

Published on: August 4, 2021

Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells

Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells

Published on: October 13, 2023

Author Spotlight: Multiplex Immunohistochemistry for Understanding Immune Regulation by Uterine NK Cells in Pregnancy

Author Spotlight: Multiplex Immunohistochemistry for Understanding Immune Regulation by Uterine NK Cells in Pregnancy

Published on: October 25, 2024

Area of Science:

Reproductive Immunology
Immunology
Obstetrics & Gynecology

Background:

Recurrent miscarriage (RM) affects 40-50% of women without identifiable causes.
Successful pregnancy relies on a shift from pro-inflammatory Th1 to anti-inflammatory Th2 immune responses.
Immune factors are increasingly implicated in unexplained RM.

Purpose of the Study:

To explore the role of immune cells and proteins in pregnancy.
To review immune-based therapies for RM.
To identify gaps in understanding treatment efficacy and patient selection.

Main Methods:

Literature review of immunological factors in pregnancy.
Analysis of immune-based therapies for recurrent miscarriage.
Assessment of current knowledge on treatment mechanisms and adverse effects.

Main Results:

Unexplained RM may stem from immunological dysregulation.
Various immune-based therapies exist with inconsistent efficacy.
Lack of understanding regarding treatment mechanisms, side effects, and patient selection markers persists.

Conclusions:

Further placebo-controlled studies are essential for idiopathic recurrent miscarriage.
Improved understanding of immune function is crucial for developing targeted therapies.
Reliable markers for selecting patients for immunomodulatory treatments are needed.